SOL Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.66M | Sell |
|
|||||
|
2025
Q2 | $1.82M | Sell |
|
|||||
|
2025
Q1 | $2.44M | Sell |
|
|||||
|
2024
Q4 | $2.78M | Sell |
|
|||||
|
2024
Q3 | $3.17M | Buy |
|
|||||
|
2024
Q2 | $2.96M | Buy |
|
|||||
|
2024
Q1 | $3.01M | Buy |
|
|||||
|
2023
Q4 | $2.16M | Buy |
|
|||||
|
2023
Q3 | $754K | Buy |
|
|||||
|
2023
Q2 | $496K | Buy |
|
|||||
|
2023
Q1 | $372K | Buy |
|
|||||
|
2022
Q4 | $376K | Buy |
|
|||||
|
2022
Q3 | $289K | Buy |
|
|||||
|
2022
Q2 | $249K | Buy |
|
|||||
|
2022
Q1 | $247K | Buy |
|
|||||
|
2021
Q4 | $213K | Buy |
|
|||||
|
2021
Q3 | $214K | Hold |
|
|||||
|
2021
Q2 | $230K | Hold |
|
|||||
|
2021
Q1 | $231K | Hold |
|
|||||
|
2020
Q4 | $239K | Buy |
|